APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 12 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,388 | +31.1% | 1,000 | 0.0% | 0.00% | – |
| Q1 2023 | $1,822 | +20.9% | 1,000 | 0.0% | 0.00% | – |
| Q4 2022 | $1,507 | -24.6% | 1,000 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | -100.0% | 1,000 | -100.0% | 0.00% | -100.0% |
| Q2 2022 | $12,459,000 | -5.6% | 8,325,000 | 0.0% | 0.00% | +33.3% |
| Q1 2022 | $13,203,000 | -4.4% | 8,325,000 | -8.9% | 0.00% | 0.0% |
| Q4 2021 | $13,816,000 | -19.3% | 9,138,000 | -34.5% | 0.00% | -25.0% |
| Q3 2021 | $17,120,000 | -34.5% | 13,960,000 | -1.6% | 0.00% | -33.3% |
| Q2 2021 | $26,151,000 | +226.7% | 14,183,000 | +148.8% | 0.01% | +200.0% |
| Q1 2021 | $8,004,000 | -42.1% | 5,701,000 | -30.8% | 0.00% | -33.3% |
| Q4 2020 | $13,812,000 | +51.5% | 8,233,000 | -2.2% | 0.00% | 0.0% |
| Q3 2020 | $9,117,000 | – | 8,420,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 39,528,000 | $49,938,921 | 2.17% |
| LINDEN ADVISORS LP | 15,000,000 | $18,816,676 | 0.19% |
| Verition Fund Management LLC | 12,454 | $15,645,338 | 0.18% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,766,000 | $14,863,606 | 0.17% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,017,000 | $1,284,573 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 12,242,000 | $15,379 | 0.02% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 300,000 | $371,070 | 0.01% |
| D. E. Shaw & Co., Inc. | 5,000,000 | $6,267,238 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CITIGROUP INC | 504,000 | $623,398 | 0.00% |